News Focus
News Focus
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

Re: pollyvonwog post# 9819

Friday, 10/26/2012 4:14:54 PM

Friday, October 26, 2012 4:14:54 PM

Post# of 20689
I see no reason that approvals will come before or at patent expiration, 2015.

I also see no reason at this point that Mylan isn't in the game along with Momenta. I'm also confused as to what Synthon BV has up its sleeve regarding their GTR comparison study.

Copaxone's 'generic' position doesn't seem as positive as once thought.